avapro has been researched along with Acute Coronary Syndrome in 2 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montalescot, G | 2 |
| Drexler, H | 2 |
| Gallo, R | 1 |
| Pearson, T | 1 |
| Thoenes, M | 1 |
| Bhatt, DL | 1 |
| Beygui, F | 1 |
| Silvain, J | 1 |
| Pena, A | 1 |
| Bellemain-Appaix, A | 1 |
| Collet, JP | 1 |
| Bhatt, D | 1 |
| Vicaut, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Comparison of a Two-month Regimen of Irbesartan Versus Enalapril on Cardiovascular Markers in Patients With Acute Coronary Syndrome Without ST Segment Elevation.[NCT00296218] | Phase 3 | 440 participants | Interventional | 2006-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for avapro and Acute Coronary Syndrome
| Article | Year |
|---|---|
Effect of irbesartan and enalapril in non-ST elevation acute coronary syndrome: results of the randomized, double-blind ARCHIPELAGO study.
Topics: Acute Coronary Syndrome; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzym | 2009 |
Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Biomarker | 2010 |